ArticleJournal of diabetes investigation2015

Effect and cardiovascular safety of adding rosiglitazone to insulin therapy in type 2 diabetes: A meta-analysis.

Yu Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.